Tectonic Therapeutic (TECX) Competitors $15.25 -0.41 (-2.62%) Closing price 04:00 PM EasternExtended Trading$15.56 +0.31 (+2.03%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TECX vs. COLL, NUVB, PGEN, WVE, MAZE, PRAX, TRVI, ORIC, PHAR, and CRONShould you be buying Tectonic Therapeutic stock or one of its competitors? The main competitors of Tectonic Therapeutic include Collegium Pharmaceutical (COLL), Nuvation Bio (NUVB), Precigen (PGEN), WAVE Life Sciences (WVE), Maze Therapeutics (MAZE), Praxis Precision Medicines (PRAX), Trevi Therapeutics (TRVI), Oric Pharmaceuticals (ORIC), Pharming Group (PHAR), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry. Tectonic Therapeutic vs. Its Competitors Collegium Pharmaceutical Nuvation Bio Precigen WAVE Life Sciences Maze Therapeutics Praxis Precision Medicines Trevi Therapeutics Oric Pharmaceuticals Pharming Group Cronos Group Tectonic Therapeutic (NASDAQ:TECX) and Collegium Pharmaceutical (NASDAQ:COLL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends. Which has more risk and volatility, TECX or COLL? Tectonic Therapeutic has a beta of 3.21, meaning that its share price is 221% more volatile than the S&P 500. Comparatively, Collegium Pharmaceutical has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Does the media favor TECX or COLL? In the previous week, Collegium Pharmaceutical had 2 more articles in the media than Tectonic Therapeutic. MarketBeat recorded 2 mentions for Collegium Pharmaceutical and 0 mentions for Tectonic Therapeutic. Collegium Pharmaceutical's average media sentiment score of 1.15 beat Tectonic Therapeutic's score of 0.00 indicating that Collegium Pharmaceutical is being referred to more favorably in the news media. Company Overall Sentiment Tectonic Therapeutic Neutral Collegium Pharmaceutical Positive Do institutionals & insiders have more ownership in TECX or COLL? 62.6% of Tectonic Therapeutic shares are held by institutional investors. 38.0% of Tectonic Therapeutic shares are held by insiders. Comparatively, 2.5% of Collegium Pharmaceutical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer TECX or COLL? Tectonic Therapeutic presently has a consensus price target of $80.29, suggesting a potential upside of 426.46%. Collegium Pharmaceutical has a consensus price target of $42.33, suggesting a potential upside of 23.49%. Given Tectonic Therapeutic's higher probable upside, research analysts plainly believe Tectonic Therapeutic is more favorable than Collegium Pharmaceutical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Collegium Pharmaceutical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.25 Which has better earnings and valuation, TECX or COLL? Collegium Pharmaceutical has higher revenue and earnings than Tectonic Therapeutic. Tectonic Therapeutic is trading at a lower price-to-earnings ratio than Collegium Pharmaceutical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTectonic TherapeuticN/AN/A-$57.98M-$4.04-3.77Collegium Pharmaceutical$631.45M1.71$69.19M$1.0432.96 Is TECX or COLL more profitable? Collegium Pharmaceutical has a net margin of 5.13% compared to Tectonic Therapeutic's net margin of 0.00%. Collegium Pharmaceutical's return on equity of 97.28% beat Tectonic Therapeutic's return on equity.Company Net Margins Return on Equity Return on Assets Tectonic TherapeuticN/A -30.13% -28.33% Collegium Pharmaceutical 5.13%97.28%13.87% SummaryCollegium Pharmaceutical beats Tectonic Therapeutic on 11 of the 16 factors compared between the two stocks. Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TECX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECX vs. The Competition Export to ExcelMetricTectonic TherapeuticMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$293.03M$3.31B$6.04B$10.53BDividend YieldN/A2.25%5.68%4.67%P/E Ratio-3.7721.5976.3926.55Price / SalesN/A462.18578.72230.86Price / CashN/A46.3737.8961.20Price / Book1.609.8412.546.48Net Income-$57.98M-$52.59M$3.30B$277.02M7 Day Performance3.67%5.84%28,086.98%1.84%1 Month Performance-8.41%12.13%30,478.96%8.29%1 Year Performance-49.13%26.32%35,729.70%36.66% Tectonic Therapeutic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECXTectonic Therapeutic3.0853 of 5 stars$15.25-2.6%$80.29+426.5%-44.1%$293.03MN/A-3.77120Positive NewsCOLLCollegium Pharmaceutical4.0933 of 5 stars$35.21-1.2%$42.33+20.2%-11.4%$1.11B$631.45M33.88210Positive NewsNUVBNuvation Bio2.8984 of 5 stars$3.19-2.6%$7.50+135.5%+61.0%$1.09B$7.87M-5.0760Analyst ForecastPGENPrecigen4.6321 of 5 stars$3.63-5.7%$8.25+127.3%+253.0%$1.09B$3.92M-8.68190Insider TradeAnalyst RevisionWVEWAVE Life Sciences4.5351 of 5 stars$6.79-1.8%$20.33+199.7%-15.3%$1.08B$108.30M-7.55240MAZEMaze Therapeutics4.2652 of 5 stars$24.42+3.2%$32.67+33.8%N/A$1.07B$167.50M0.00121Analyst ForecastPRAXPraxis Precision Medicines1.9484 of 5 stars$49.09+1.6%$85.56+74.3%-7.7%$1.03B$8.55M-3.98110TRVITrevi Therapeutics2.095 of 5 stars$8.37-2.2%$21.75+160.0%+202.3%$1.02BN/A-20.0020ORICOric Pharmaceuticals4.4757 of 5 stars$10.46-3.3%$17.29+65.2%+16.6%$1.02BN/A-5.5480Insider TradePHARPharming Group2.3177 of 5 stars$14.73-0.7%$30.00+103.7%+79.2%$1.01B$297.20M-113.31280News CoverageAnalyst DowngradeShort Interest ↑High Trading VolumeCRONCronos Group1.5216 of 5 stars$2.62+1.0%N/A+24.9%$997.43M$117.61M52.10450 Related Companies and Tools Related Companies Collegium Pharmaceutical Competitors Nuvation Bio Competitors Precigen Competitors WAVE Life Sciences Competitors Maze Therapeutics Competitors Praxis Precision Medicines Competitors Trevi Therapeutics Competitors Oric Pharmaceuticals Competitors Pharming Group Competitors Cronos Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECX) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredChina’s message to TrumpPorter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
